SECOR Capital Advisors, LP - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 84 filers reported holding SYNTA PHARMACEUTICALS CORP in Q3 2015. The put-call ratio across all filers is 1.53 and the average weighting 1.0%.

Quarter-by-quarter ownership
SECOR Capital Advisors, LP ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q3 2015$42,000
-46.2%
23,964
-31.7%
0.01%
-53.6%
Q2 2015$78,000
+14.7%
35,0870.0%0.03%
+3.7%
Q1 2015$68,000
-26.9%
35,0870.0%0.03%
-30.8%
Q4 2014$93,00035,0870.04%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q3 2015
NameSharesValueWeighting ↓
CAXTON CORP 23,634,349$149,133,00099.87%
Perceptive Advisors 4,762,472$30,052,0001.24%
QVT Financial LP 1,750,285$11,044,0000.75%
NBW CAPITAL LLC 404,721$2,554,0000.45%
Tekla Capital Management LLC 489,750$3,090,0000.34%
MILES CAPITAL, INC. 57,904$365,0000.21%
FULLER & THALER ASSET MANAGEMENT, INC. 435,200$2,746,0000.16%
Old West Investment Management, LLC 49,136$310,0000.15%
Integre Asset Management, LLC 84,420$533,0000.14%
SABBY MANAGEMENT, LLC 250,952$1,584,0000.10%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders